| Public Notice | Monitoring | N/A | N/A | Oct 23, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 23, 2025 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2025 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 21, 2025 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 15, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 15, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 15, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 15, 2025 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 30, 2025 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 30, 2025 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 30, 2025 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 30, 2025 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 30, 2025 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 30, 2025 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 30, 2025 | Active | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Aug 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 11, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 11, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 11, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 11, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 11, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Aug 10, 2025 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Aug 10, 2025 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 27, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 27, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 23, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 23, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 23, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 23, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 23, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 15, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 15, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 23, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 18, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 18, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 18, 2025 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | May 12, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 12, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 12, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 5, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 5, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 5, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 5, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 5, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 24, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 24, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 12, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 12, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 12, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 12, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 12, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 7, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 7, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 7, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 7, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 7, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 7, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 7, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 7, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 7, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 7, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 23, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 23, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 17, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 17, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Mar 17, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Mar 17, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Mar 17, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 10, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 10, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 10, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Mar 10, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Feb 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Feb 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Feb 10, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 27, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 14, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 14, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 14, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 16, 2024 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 16, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 16, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 10, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 3, 2024 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 3, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 3, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 10, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Oct 6, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 6, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 6, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 8, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 5, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 5, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 5, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 5, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 5, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 5, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 5, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 17, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 17, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 17, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 17, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 17, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 17, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 26, 2024 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 26, 2024 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 26, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 19, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 19, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 11, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 11, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 11, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 10, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 10, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 10, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 19, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 19, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 19, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 10, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 10, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 8, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 8, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 20, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 20, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 20, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 20, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Feb 10, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 10, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 10, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 19, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 19, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jan 19, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 19, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 19, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 19, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 11, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 11, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 11, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 11, 2024 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Dec 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 26, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 26, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 18, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 18, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 18, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Nov 18, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 18, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 18, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Oct 26, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Oct 26, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Oct 26, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 26, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 26, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Oct 20, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Oct 20, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 10, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 24, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 24, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jul 24, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 24, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 10, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 26, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 26, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 26, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 26, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 12, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 12, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 10, 2023 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,3,7,8-TCDD | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Picloram | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dinoseb | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| ETHYLENE DIBROMIDE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4,5-TP | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 1,2-DIBROMO-3-CHLOROPROPANE | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Dalapon | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| 2,4-D | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Groundwater Rule | Health-Based | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Groundwater Rule | Health-Based | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Dec 10, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 10, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 10, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 11, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 11, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 11, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Mar 17, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Mar 17, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Mar 17, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Feb 14, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 14, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 14, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Feb 14, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrite | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 19, 2021 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Sep 19, 2021 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |